Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000036.xml
Laryngorhinootologie 2022; 101(04): 327-330
DOI: 10.1055/a-1540-7017
DOI: 10.1055/a-1540-7017
Der interessante Fall
Tumortherapie synchroner Malignome verschiedener Organe – ein Fall für die interdisziplinäre Onkologie
Therapies for synchronous malignomas – the importance of interdisciplinary oncology
Schlüsselwörter
Interdisziplinarität - Medikamentöse Tumortherapie - simultan - EML-ALK - Induktionstherapie - interdisciplinarity - medical oncology - synchronous - EML-ALK - induction chemotherapyPublication History
Received: 24 May 2021
Accepted after revision: 28 June 2021
Article published online:
23 July 2021
© 2021. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Jiao F, Yao L, Zhou J. et al. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients. Asian Pac. J. Cancer Prev 2014; 15: 331-334 DOI: 10.7314/apjcp.2014.15.1.331. (PMID: 24528052)
- 2 Bagri P. et al. Double primary malignancies: a clinical & pathological analysis report from a regional cancer institute in India. Iran. J. cancer Prev 2014; 7: 66-72 (PMID: 25250152)
- 3 Donin N. et al. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer 2016; 122 (19) 3075-3086 DOI: 10.1002/cncr.30164. (PMID: 27377470)
- 4 Luttke M, Späth R, Marschner S. et al. Induktionschemotherapie mit Cisplatin und Gemcitabin, gefolgt von Radiochemotherapie bei Nasopharynxkarzinomen Induction Chemotherapy with Gemcitabine and Cisplatin followed by Radiochemotherapy in locally advanced Nasopharyngeal Carcinoma. Strahlentherapie und Onkol 2020; 196 (08) 740-742 DOI: 10.1007/s00066-020-01644-6. (PMID: 32524161)
- 5 Zhang Y. et al. Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma. N Engl J Med 2019; 381: 1124-1135 DOI: 10.1056/NEJMoa1905287. (PMID: 31150573)
- 6 Wong D. et al. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS. Cancer 2009; 115: 1723-1733 DOI: 10.1002/cncr.24181. (PMID: 19170230)
- 7 Soda M, Choi Y, Enomoto M. et al. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature 2007; 448: 561-566 DOI: 10.1038/nature05945. (PMID: 17625570)
- 8 Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik, Therapie und Nachsorge des Larynxkarzinoms, Kurzversion 1.1 – Januar 2019, AWMF-Registernummer: 017 – 076OL.